Technical Analysis for RSLS - ReShape Lifesciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | -1.37% | |
| NR7 | Range Contraction | -1.37% | |
| Narrow Range Bar | Range Contraction | -1.37% | |
| Inside Day | Range Contraction | -1.37% | |
| BB Squeeze Ended | Range Expansion | -1.37% | |
| Oversold Stochastic | Weakness | -1.37% | |
| Bollinger Band Squeeze | Range Contraction | -4.73% | |
| Stochastic Reached Oversold | Weakness | -4.73% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 16 hours ago |
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Fell Below Previous Day's Low | about 16 hours ago |
| Down 2 % | about 16 hours ago |
| Down 1% | about 16 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/06/2024
ReShape Lifesciences, Inc. Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Obesity Metabolic Disease Neuromodulation Diabetes Mellitus Digestive System Surgery Bariatrics Laparoscopy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 34.22 |
| 52 Week Low | 4.6 |
| Average Volume | 283,638 |
| 200-Day Moving Average | 9.50 |
| 50-Day Moving Average | 6.02 |
| 20-Day Moving Average | 5.56 |
| 10-Day Moving Average | 5.35 |
| Average True Range | 0.64 |
| RSI (14) | 41.18 |
| ADX | 31.71 |
| +DI | 18.22 |
| -DI | 13.70 |
| Chandelier Exit (Long, 3 ATRs) | 5.00 |
| Chandelier Exit (Short, 3 ATRs) | 6.79 |
| Upper Bollinger Bands | 6.15 |
| Lower Bollinger Band | 4.97 |
| Percent B (%b) | 0.06 |
| BandWidth | 21.33 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.23 |
| MACD Histogram | -0.0195 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.52 | ||||
| Resistance 3 (R3) | 5.56 | 5.44 | 5.44 | ||
| Resistance 2 (R2) | 5.44 | 5.32 | 5.42 | 5.41 | |
| Resistance 1 (R1) | 5.24 | 5.24 | 5.18 | 5.20 | 5.39 |
| Pivot Point | 5.12 | 5.12 | 5.09 | 5.10 | 5.12 |
| Support 1 (S1) | 4.92 | 5.00 | 4.86 | 4.88 | 4.69 |
| Support 2 (S2) | 4.80 | 4.92 | 4.78 | 4.67 | |
| Support 3 (S3) | 4.60 | 4.80 | 4.64 | ||
| Support 4 (S4) | 4.56 |
